Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Career Basics

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 11 December 1992:
Vol. 258. no. 5089, p. 1719
DOI: 10.1126/science.258.5089.1719-a
Prev | Table of Contents | Next

Articles

Corrections and Clarifications

The table accompanying Larry Thompson's Research News article "At age 2, gene therapy enters a growth phase" (30 Oct., p. 744) incorrectly identified the principal investigators of gene therapy trials to treat kidney cancer and malignant melanoma being conducted at Memorial Sloan-Kettering Cancer Center and of a brain cancer experiment at the National Institutes of Health. The principal investigator of the Sloan-Kettering trials is Bernd Gansbacher, and the brain cancer study is being led by Edward Oldfield of the National Institute of Neurological Disorders and Stroke.

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)